Pharmaceutical Product Development Inc. (PPDI:NASDAQ)
Snapshot of Pharmaceutical Product Development Inc. (PPDI)
|
OPEN
$21.12
|
PREVIOUS CLOSE
$21.02
|
|
|
DAY HIGH
$21.52
|
DAY LOW
$21.09
|
|
|
52 WEEK HIGH
01/2/09 - $29.53
|
52 WEEK LOW
04/22/09 - $17.97
|
|
|
MARKET CAP
2.5B
|
AVERAGE VOLUME 3 mo
1.1M
|
|
|
DILUTED EPS TTM
$1.42
|
SHARES OUTSTANDING
118.2M
|
|
|
EX-DATE
12/11/09
|
P/E TTM
15.1x
|
|
|
DIVIDEND
$0.60
|
DIVIDEND YIELD
2.81%
|
|
| K = Thousands M = Millions B = Billions | ||
related business week news
S&P's top picks among companies that serve the pharmaceutical and biotech industries: Covance and Thermo Fisher Scientific
S&P likes the fundamentals of one of the stronger-performing subindustries this year, and has buy ratings on seven names
PPDI Details
Pharmaceutical Product Development Inc., a contract research organization, provides drug discovery and development services, post-approval expertise, and compound partnering programs. Its Discovery Sciences segment offers preclinical program design, toxicology consulting, lab services, and technical writing and regulatory submissions, as well as compound collaboration programs. The Development segment provides Phase 1 clinical testing, lab services, and Phases 2 through 4 clinical trial management services (such as study design, investigator recruitment, clinical data management and bio-statistical analysis). The company also offers product launch services and patient and disease registry programs, and has operations worldwide. Pharmaceutical Product Development, founded in 1985, is headquartered in Wilmington, N.C.
PPDI Top Compensated Officers
Key developments for Pharmaceutical Product Development Inc. (PPDI)
Pharmaceutical Product Development Inc. declared a cash dividend for the fourth quarter of 2009 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share. The record date for the fourth quarter dividend is December 15, 2009, and the payment date is December 29, 2009.
To discuss the best clinical strategy for China and East Asia
Pharmaceutical Product Development Inc. expected to Report Fiscal Year 2009 Results on February 8, 2010. This event was calculated by Capital IQ (Created on October 28, 2009).
BusinessWeek Rankings
Stock Quotes
| Recently Viewed | |||
| PPDI | $21.38 USD | +0.36 |  |
|---|---|---|---|
| KFY | $16.46 USD | +0.16 |  |
| MORN | $47.88 USD | -0.04 |  |
| RUTH | $2.30 USD | -0.11 |  |
| 1605 (JP) | ¥712,000.00 JPY | 0.00 |  |
Market data is delayed at least 20 minutes.
PPDI Competitors
| Company | Last | Change |
| Charles River Laboratories Interntnl Inc | $32.59 USD | +0.15 |
| Covance Inc | $53.59 USD | +0.70 |
| Icon | €15.10 EUR | 0.00 |
| Millipore Corp | $68.30 USD | +0.57 |
| West Pharmaceutical Services Inc | $39.93 USD | +0.90 |
| View Industry Companies | ||
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | PPDI | Industry Range |
| Price/Earnings | 14.7x |
|
| Price/Sales | 1.7x |
|
| Price/Book | 1.9x |
|
| Price/Cash Flow | 9.9x |
|
| TEV/Sales | 1.3x |
|
|
PPDI |
||
PPDI transactions
| Type Date |
Target |
|
Merger/Acquisition
October 27, 2009 |
Excel PharmaStudies, Inc. |
|
Spin-Off/Split-Off
October 27, 2009 |
Pharmaceutical Product Development Inc., Compound Partnering Business |
Companies Toolbox
Update/report
Submit private company
Upload your company video
Newsletter
Blogs
RSS feeds
Podcasts
VideosSEARCH FOR JOBS
Post a Job- Morrisville, NC-Ppd
- Cambridge, MA-Ppd
- Morrisville, NC-Ppd
- Wayne, PA-Ppd
Jobs by SimplyHired
Recommend A Data Enhancement Or Correction
For Pharmaceutical Product Development Inc. (PPDI) Snapshot
Submitting this data update / error report instantly puts the correct information in the hands of our researcher, who will investigate your report and, if necessary, make the changes to the company profile. Be sure to fill out the form completely.
Please indicate in which section the error appears. Section headers are in light gray type at the top of each CIC page module.
Please indicate which data is in error.
Please provide your name and email address in case our researchers need to get in touch with you as they investigate the error.
Describe why you feel the data point is incorrect and indicate sources our researchers should check when they investigate the error.
